SOLEUS CAPITAL MANAGEMENT, L.P. – Inhibrx Biosciences, Inc. Transaction History
SOLEUS CAPITAL MANAGEMENT, L.P. portfolio value:
$6.53M
portfolio value
Inhibrx Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 363.90K shares | 6.53M | $17.95 | 363.90K |
| Q4 2021 | share | Decrease | -100.00% | -97.97K shares | -3.26M | $43.06 | 0 |
| Q3 2021 | share | Decrease | -59.64% | -144.81K shares | -3.41M | $33.31 | 97.97K |
| Q2 2021 | share | Decrease | -39.53% | -158.70K shares | -1.37M | $27.52 | 242.78K |
| Q1 2021 | share | Increase | +87.78% | 187.68K shares | 1.00M | $20.07 | 401.49K |
| Q4 2020 | share | Decrease | -47.40% | -192.69K shares | -268K | $32.97 | 213.80K |
| Q3 2020 | share | Increase | 0.00% | 406.5K shares | 7.31M | $18 | 406.5K |